Product
BGB-DXP604
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase 1, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BGB-DXP604 Alone and in Combination With BGB-DXP593 in Healthy SubjectsStatus: Completed, Estimated PCD: 2021-05-21